SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Ditchdigger who wrote (7440)10/4/1998 9:25:00 PM
From: Robert K.  Respond to of 17367
 
Agree with that DD. Here is a article where the first line lends credance to the probability of a bpi use in pneumonia/ards.
The excerpt>
>Microvasc Res 1998 Sep;56(2):71-84
Effects of Endotoxin on Lung Pericytes in Vitro.

Khoury J, Langleben D
Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, H3T 1E2, Canada
[Record supplied by publisher]

Lipopolysaccharide released during bacterial sepsis causes acute lung injury and ARDS. Pulmonary microvascular injury is a feature of ARDS, and vascular remodeling develops, leading to pulmonary hypertension.



To: Ditchdigger who wrote (7440)10/4/1998 10:09:00 PM
From: Robert K.  Respond to of 17367
 
Ahhhh, but a facor i didnt consider is that HK has been on holiday since wednesday, and now must "adjust" to last week. Thats whats weighing down things right now. HK opened off 3.5%. Once it settles in they we will see the true course in asia IMO. Right now 6 of 8 markets are off.



To: Ditchdigger who wrote (7440)10/5/1998 6:54:00 AM
From: Robert K.  Read Replies (2) | Respond to of 17367
 
Off topic-DD mixed bag, asia down, europe up. I might go another day.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News